Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 289
Selected: 0
NCT IDTitle
NCT03019666Ph I Trial of NAM NK Cells and IL-2 for Adult Pts With MM and NHL
NCT00258427Hematopoietic Stem Cell Transplantation in High Risk Patients With Fanconi Anemia
NCT06792825HM2023-43:Ph 2 Trial of Tafasitamab With Lenalidomide+Rituximab in Treatment-naive FL and MZL
NCT05338658Study of PAT in Patients With Solid Tumor Cancers
NCT04363346Study of FT516 for the Treatment of COVID-19 in Hospitalized Patients With Hypoxia
NCT04055844Multi-Ctr PII Cmb.Modality Tx Ruxolitinib, Decitabine, and DLI for Post HSCT in AML/MDS
NCT06693986Adenovirus (RGDCRAdCOX2F)
NCT01526603High Dose Chemotherapy and Autologous Transplant for Neuroblastoma
NCT01105650Allogeneic Natural Killer (NK) Cells for Ovarian, Fallopian Tube, Peritoneal and Metastatic Breast Cancer
NCT03850691Radiation and Combination Immunotherapy for Melanoma
NCT02227797MT2013-37R: Voriconazole Monitoring in Pediatric Stem Cell Transplant Patients
NCT00455312Stem Cell Transplant (SCT) for Dyskeratosis Congenita or SAA
NCT05708924MT2021-27 FT538 Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
NCT05447156QuitGuide for American Indians: Aims 2 & 3
NCT00005984Cyclophosphamide and Filgrastim Followed By SCT in Patients With Chronic or Accelerated Phase Myelogenous Leukemia
NCT01033552Biochemical Correction of Severe EB by Allo HSCT and "Off-the-shelf" MSCs
NCT01572636Laronidase (Aldurazyme TM) Enzyme Replacement Therapy With Hematopoietic Stem Cell Transplant for Hurler Syndrome
NCT03050216QUILT-3.033: Haplo NK With SQ ALT-803 for Adults With Relapsed or Refractory AML
NCT01681875Project 1, Study 1: Investigating the Impact of Nicotine Using Spectrum Cigarettes
NCT02145039Reduced Intensity Conditioning and Haploidentical Related Bone Marrow for Patients With Hematologic Diseases
NCT03316456Gut Microbiota in Intestinal Barrier Damage in Acute Leukemia Patients Undergoing Inpatient Induction
NCT01593670Decitabine and Vorinostat Conditioning Followed by CD3-/CD19- NK Cells Infusion for High Risk Myelodysplastic Syndromes
NCT04530695Diagnosis and Treatment of Periodontal Disease in Patients With AML
NCT00167219Stem Cell Transplant for Juvenile Myelomonocytic Leukemia (JMML)
NCT01400672Imiquimod/Brain Tumor Initiating Cell (BTIC) Vaccine in Brain Stem Glioma
NCT04882423Vegetable Intake Effect on Heterocyclic Amine Metabolism
NCT00686556Total Marrow Irradiation for Refractory Acute Leukemia
NCT00376805Allogeneic Natural Killer (NK) Cells in Patients With Advanced Metastatic Breast Cancer
NCT02500472Investigation of Kava Effects on NNK Metabolism
NCT04003805Biomarkers of Exposure and Effect in Standardized Research E-cigarette (SREC) Users
NCT00176930Stem Cell Transplant for Hematological Malignancy
NCT02845414Study of CD133KDEL Toxin in the Treatment for Solid Tumors
NCT01677949Clofarabine, Cyclophosphamide and Etoposide for Minimal Residual Disease Positive Acute Leukemia
NCT01163201T-Regulatory Cell and CD3 Depleted Double Umbilical Cord Blood Transplantation in Hematologic Malignancies
NCT02162420Hematopoietic Stem Cell Transplant for Dyskeratosis Congenita or Severe Aplastic Anemia
NCT00428194Erlotinib, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB-Stage IVA Cervical Cancer
NCT00352118Combination Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer
NCT01705288Implementation of a Rapid Recovery Program in Gynecologic Oncology Surgery: A Pilot Study
NCT01288222Selecting a Favorable KIR Donor in Unrelated HCT for AML
NCT02988466Reduced Intensity (RIC) Conditioning And Transplantation of HLA-Haplo-HCT
NCT05805605Allo HSCT Using RIC and PTCy for Hematological Diseases
NCT00287911Topotecan, Cisplatin, and Radiation Therapy in Treating Patients With Advanced Cervical Cancer
NCT02525029Study of Pregnyl as Adjunct Therapy for High-Risk or Refractory Acute GVHD
NCT02693665Building Evidence for Effective Palliative/End of Life Care for Teens With Cancer
NCT07008638Phase I/II Clinical Trial of Proteasome Inhibitor in Combination With CPX-351 for the Treatment of Newly-Diagnosed TP53-mutated Acute Myeloid Leukemia (AML)
NCT02118285Intraperitoneal Natural Killer Cells and INCB024360 for Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
NCT00619021Bronchial Artery Infusion of Gemcitabine in Treating Patients With Recurrent or Progressive Non-Small Cell Lung Cancer
NCT03081780Open Label NK Cell Infusion (FATE-NK100) With Subq IL-2 in Adults With AML
NCT03981705Assessment of Complete Pathologic Response After Neoadjuvant Chemotherapy for Breast Cancer
NCT01451502Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units